Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest California Institute for Regenerative Medicine Stories

2013-02-13 08:28:49

-- Treatment being developed would use encapsulation to protect new insulin-producing cells derived from a stem cell precursor -- NEW YORK and SAN FRANCISCO, Feb. 13, 2013 /PRNewswire-USNewswire/ -- JDRF, the world's largest non-profit supporter of type 1 diabetes (T1D) research, and the California Institute for Regenerative Medicine (CIRM), California's stem cell agency, announced that they are providing additional funding for the development of a novel stem cell therapy by San...

2012-12-06 16:24:17

SANTA MONICA, Calif., Dec. 6, 2012 /PRNewswire-USNewswire/ -- Consumer Watchdog Thursday welcomed a report from the prestigious Institute of Medicine (IOM) calling for sweeping reforms in governance at California's stem cell agency and an end to the board's built-in conflicts of interest. The report said that "far too many board members represent organizations" that receive funding or benefit from the stem cell agency. The IOM said that the board's oversight function should be separated from...

2012-11-21 12:23:42

SAN FRANCISCO, Nov. 21, 2012 /PRNewswire-USNewswire/ -- The ALS Association Golden West Chapter congratulates Diane Winokur on her recent appointment by California Lieutenant Governor Gavin Newsom as the amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) representative of the Independent Citizen's Oversight Committee (ICOC), which is the governing body of the California Institute for Regenerative Medicine (CIRM). CIRM was established through the passage of Proposition 71, the...

2012-10-26 07:23:59

SAN DIEGO, Oct. 26, 2012 /PRNewswire/ -- ViaCyte, Inc., a leading regenerative medicine company developing a transformative cell therapy for treatment of diabetes, announced today that it has received a $10.1 million Strategic Partnership Award from the California Institute for Regenerative Medicine (CIRM). (Logo: http://photos.prnewswire.com/prnh/20121026/LA00871LOGO-a) (Logo: http://photos.prnewswire.com/prnh/20121026/LA00871LOGO-b) ViaCyte's innovative stem cell-based therapy for...

2011-12-13 09:50:00

--Goal of new JDRF research is to restore insulin production in people with type 1 diabetes-- NEW YORK, Dec. 13, 2011 /PRNewswire-USNewswire/ -- JDRF announced today its support of a pioneering diabetes research program that is developing a first-of-its-kind cell therapy for type 1 diabetes (T1D) and other forms of insulin-dependent diabetes. The therapy is a combination product that packages immature cells made from human embryonic stem cells (hESCs) that over time develop into mature...

2010-10-24 00:13:41

UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure. San Francisco, CA (Vocus) October 22, 2010 UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure. The goal of the grants is for...

2010-04-09 09:49:00

WINSTON-SALEM, N.C., April 9 /PRNewswire-USNewswire/ -- Leaders in the field of regenerative medicine spoke about the potential to transform medicine through new treatments that focus not just on treating disease - but on cures - at the first annual Translational Regenerative Medicine Forum. Attended by more than 400 people from across the world, the event was sponsored by the Regenerative Medicine Foundation. "We are excited to bring together representatives from all facets of this...

2010-03-12 11:15:00

WINSTON-SALEM, N.C., March 12 /PRNewswire-USNewswire/ -- Newswise -- What regenerative medicine therapies are being applied to patients today? What hurdles stand between stem cell therapies and real treatments in the clinic? Keynote speakers at the upcoming inaugural Translational Regenerative Medicine Forum will discuss these topics as well as provide an update on various national and regional stem cell initiatives. The forum, set for April 6-8 in Winston-Salem, is an annual event to focus...

2009-12-10 18:00:00

SAN DIEGO, Dec. 10 /PRNewswire/ -- Kornberg Associates | Architects (www.kornberg.com) has converted part of an existing building (Keen Hall), including a previously unused covered open area, into an innovative stem cell core facility for the University of California, Riverside. Ken Kornberg, president and founder, made the announcement. "A key project element was to ensure that although the facility was integrated into the campus security system, access control is independent from the...

2009-10-28 16:39:00

SAN DIEGO, Oct. 28 /PRNewswire/ -- Novocell, Inc., a preclinical stage diabetes company, today announced that it will receive a Disease Team award totaling $20 million from the California Institute for Regenerative Medicine (CIRM). The Disease Team includes a group of scientists at the University of California, San Francisco (UCSF), led by Dr. Jeff Bluestone, which is contracted to receive $2.8 million. The funding will advance Novocell's development of a first in kind cellular therapy for...